SCHEMBL3886903

SCHEMBL3886903

COC(=O)c1cc(C(C)=O)cc(C(=O)NC(C)c2ccccc2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.54
GAA P10253 1/20 0.54
PKM P14618 1/20 0.54
LMNA P02545 3/20 0.54
NPC1 O15118 1/20 0.54
GPR139 Q6DWJ6 4/20 0.52
HPGD P15428 2/20 0.51
HDAC6 Q9UBN7 1/20 0.51
SMN1; SMN2 Q16637 2/20 0.50
ROCK2 O75116 2/20 0.49
MAPK1 P28482 2/20 0.49
RPS6KA5 O75582 1/20 0.49
MAP4K4 O95819 1/20 0.49
CDK1 P06493 1/20 0.49
CSF1R P07333 1/20 0.49
PRKACA P17612 1/20 0.49
FLT1 P17948 1/20 0.49
RPS6KB1 P23443 1/20 0.49
CDK2 P24941 1/20 0.49
AKT1 P31749 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3886906 1.00 ALDH1A1 (0.54) ALDH1A1GAAPKMLMNANPC1
SCHEMBL7946598 0.89 ALDH1A1 (0.54) ALDH1A1GAAPKMLMNANPC1
SCHEMBL3888762 0.88 ALDH1A1 (0.67) ALDH1A1GAAPKMLMNANPC1
SCHEMBL3888758 0.88 ALDH1A1 (0.67) ALDH1A1GAAPKMLMNANPC1
SCHEMBL13229689 0.88 ALDH1A1 (0.53) ALDH1A1GAAPKMLMNANPC1
SCHEMBL13229356 0.88 GPR139 (0.63) ALDH1A1GAAPKMLMNANPC1
SCHEMBL3889347 0.87 ALDH1A1 (0.57) ALDH1A1GAAPKMLMNANPC1
SCHEMBL3889350 0.87 ALDH1A1 (0.57) ALDH1A1GAAPKMLMNANPC1
SCHEMBL13229314 0.87 GPR139 (0.51) ALDH1A1GAAPKMLMNANPC1
SCHEMBL7866401 0.86 LMNA (0.56) ALDH1A1LMNANPC1ROCK2ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7476764-B2 Phenylcarboxyamides as beta-secretase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2009-01-13 US disclosed
US-20070032470-A1 Novel phenylcarboxyamides as beta-secretase inhibitors BRISTOL-MYERS SQUIBB COMPANY 2007-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032470-A1 Novel phenylcarboxyamides as beta-secretase inhibitors BACE1, APP, BACE2 ALDH1A1 3847/4885GAA 284/4885PKM 2576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.